Targeting estrogen to the brain via DHED does not seem to protect against metabolic dysfunction in obese OVX mice
Endocrinology · 2026
DOI: 10.1210/endocr/bqag082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, 2026. Verfasst von Celine Camon und 12 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Neuroendocrinology, University of Otago, Dunedin 9016, New Zealand. Hauptthemen laut MEDLINE: Obesity, Estrogens, Brain. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Elman Poole Foundation, British Society for Neuroendocrinology, Hope Foundation for Research on Ageing.
Abstract (Originalsprache)
Menopausal hormone therapy (MHT), prescribed for climacteric symptoms including hot flushes and weight gain, contains estrogens such as 17 beta-estradiol (17βE2). However, estrogen receptor activation by MHT may increase reproductive cancers in some people. As the protective metabolic effects of 17βE2 are partly mediated through the arcuate nucleus (ARC) of the hypothalamus, restricting 17βE2 actions to the brain could serve as a safer method for MHT. The prodrug 10β,17β-dihydroxyestra-1,4-dien-3-one (DHED) is enzymatically converted into 17βE2 exclusively within the brain. DHED has already demonstrated positive benefit in rodent models of hot flushes and cognitive decline, while avoiding peripheral hormonal burden. Therefore, we hypothesized that DHED treatment in obese female mice would act within the hypothalamus to provide the same beneficial metabolic effects as 17βE2. Female mice were ovariectomized, placed on a high fat diet and split into control, 17βE2, or DHED treatment groups. Body weight, uterine weight, glucose tolerance and peripheral concentrations of luteinizing hormone were recorded, along with the expression of the progesterone receptor and kisspeptin mRNA within the ARC. Delivery of DHED at a similar dose as 17βE2 failed to improve metabolic parameters or recapitulate the hypothalamic responses induced by 17βE2. Our findings subsequently show that delivery of DHED at higher doses elicited estrogen-like actions within the brain but still failed to improve metabolic health. Additional investigations surrounding DHED's conversion to 17βE2 within the hypothalamus are warranted to conclude whether estradiol actions exclusively within the central nervous system can independently regulate protective effects on metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Neuroendocrinology, University of Otago, Dunedin 9016, New Zealand.
- Department of Integrative Biology and Physiology, University of California Los Angeles, Los Angeles, CA 90095, USA.
- Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, TX 76107, USA.
ORCID-Profile: Celine Camon, Paul B Vander, Rebecca E Campbell
Förderung
- Elman Poole Foundation
- British Society for Neuroendocrinology
- Hope Foundation for Research on Ageing
- University of Otago's Doctoral Scholarship
- University of Otago’s Doctoral Scholarship
Zitieren
APA
Camon, C., Kip, E., Lord, R., Decourt, C., Prescott, M., Clarkson, J., Sandoval, N. P., Vander, P. B., Van Veen, J. E., Prokai-Tatrai, K., Correa, S. M., Campbell, R. E., & Garratt, M. (2026). Targeting estrogen to the brain via DHED does not seem to protect against metabolic dysfunction in obese OVX mice. Endocrinology. https://doi.org/10.1210/endocr/bqag082
Vancouver
Camon C, Kip E, Lord R, Decourt C, Prescott M, Clarkson J, et al. Targeting estrogen to the brain via DHED does not seem to protect against metabolic dysfunction in obese OVX mice. Endocrinology. 2026. doi:10.1210/endocr/bqag082
BibTeX
@article{Camon2026,
author = {Camon, Celine and Kip, Elodie and Lord, Rebecca and Decourt, Caroline and Prescott, Mel and Clarkson, Jenny and Sandoval, Norma P and Vander, Paul B and Van Veen, J Edward and Prokai-Tatrai, Katalin and Correa, Stephanie M and Campbell, Rebecca E and Garratt, Michael},
title = {Targeting estrogen to the brain via DHED does not seem to protect against metabolic dysfunction in obese OVX mice},
journal = {Endocrinology},
year = {2026},
doi = {10.1210/endocr/bqag082}
}
EUVIMED